EVALUATION OF ADHERENCE TO BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN PATIENTS WITH INFLAMMATORY ARTHRITIS

被引：0
|
作者：
Lim, Y. C. [1 ]
Teo, W. G. [2 ]
Eng, M. N. [1 ]
Cheen, H. M. [1 ]
Tay, X. Y. [1 ]
Yeo, S. I. [3 ]
Lim, T. G. [1 ]
机构：
[1] Singapore Gen Hosp, Pharm, Singapore, Singapore
[2] Natl Heart Ctr Singapore, Pharm, Singapore, Singapore
[3] Singapore Gen Hosp, Rheumatol & Immunol, Singapore, Singapore
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
RHEUMATOID-ARTHRITIS;
D O I：
10.1136/annrheumdis-2018-eular.2183
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0748-HP
引用
收藏
页码：1800 / 1800
页数：1
相关论文
共 50 条
  • [41] TUBERCULOSIS RISK IN CHILDREN WITH RHEUMATIC DISEASES TREATED WITH BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS
    Kavadichanda, C.
    Ajmani, S.
    Maccora, I.
    Balan, S.
    Ramanan, A.
    Agarwal, V.
    Gupta, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1784 - 1785
  • [42] ABATACEPT IS A SUITABLE BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN PATIENTS WITH ANTI-SS-A ANTIBODIES-POSITIVE RHEUMATOID ARTHRITIS
    Horai, Y.
    Takatani, A.
    Nishino, A.
    Nakashima, Y.
    Suzuki, T.
    Fujikawa, K.
    Tsukada, T.
    Tsuboi, M.
    Matsuoka, N.
    Migita, K.
    Aramaki, T.
    Ueki, Y.
    Kawashiri, S. -Y.
    Iwamoto, N.
    Ichinose, K.
    Tamai, M.
    Nakamura, H.
    Origuchi, T.
    Kawakami, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 687 - 688
  • [43] A Practical Approach to the Use of Conventional Synthetic, Biologic and Targeted Synthetic Disease Modifying Anti-Rheumatic Drugs for the Treatment of Inflammatory Arthritis in Patients with a History of Malignancy
    Peter K. K. Wong
    Hanish Bagga
    Claire Barrett
    Geoff Chong
    Patrick Hanrahan
    Teja Kodali
    Mona Marabani
    H. Miles Prince
    John Riordan
    Phillip Swarbrick
    Ray White
    Laurel Young
    Current Rheumatology Reports, 2018, 20
  • [44] A Practical Approach to the Use of Conventional Synthetic, Biologic and Targeted Synthetic Disease Modifying Anti-Rheumatic Drugs for the Treatment of Inflammatory Arthritis in Patients with a History of Malignancy
    Wong, Peter K. K.
    Bagga, Hanish
    Barrett, Claire
    Chong, Geoff
    Hanrahan, Patrick
    Kodali, Teja
    Marabani, Mona
    Prince, H. Miles
    Riordan, John
    Swarbrick, Phillip
    White, Ray
    Young, Laurel
    CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (10)
  • [45] Exploring the relationship between utilization patterns of biologic disease-modifying anti-rheumatic drugs and disease activity in rheumatoid arthritis patients
    Convertino, Irma
    Cazzato, Massimiliano
    Tillati, Silvia
    Giometto, Sabrina
    Gini, Rosa
    Valdiserra, Giulia
    Cappello, Emiliano
    Ferraro, Sara
    Bonaso, Marco
    Bartolini, Claudia C.
    Paoletti, Olga
    Lorenzoni, Valentina
    Filippi, Matteo
    Turchetti, Giuseppe
    Cristofano, Michele
    Blandizzi, Corrado
    Mosca, Marta
    Lucenteforte, Ersilia
    Tuccori, Marco
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 488 - 489
  • [46] Ovarian reserve in children with juvenile idiopathic arthritis using biologic disease-modifying anti-rheumatic drugs
    Ozer, Yavuz
    Yildiz, Mehmet
    Turan, Hande
    Tarcin, Gurkan
    Aydin, Dilek Bingol
    Gunalp, Aybuke
    Haslak, Fatih
    Konte, Elif Kilic
    Aslan, Esma
    Koker, Oya
    Bayramoglu, Elvan
    Sahin, Sezgin
    Adrovic, Amra
    Barut, Kenan
    Kasapcopur, Ozgur
    Evliyaoglu, Olcay
    CLINICAL RHEUMATOLOGY, 2024, 43 (01) : 399 - 406
  • [47] Biologic disease-modifying anti-rheumatic drugs and kinase inhibitors: differences in efficacy and safety in rheumatoid arthritis
    Roy Fleischmann
    Clinical Rheumatology, 2021, 40 : 4369 - 4372
  • [48] Two Cases of High Tibial Osteotomy in Patients with Rheumatoid Arthritis Treated with Biologic Disease-modifying Anti-rheumatic Drugs
    Takahara, Yasuhiro
    Nishida, Keiichiro
    Nakashima, Hirotaka
    Ochi, Nobuaki
    Uchida, Yoichiro
    Kato, Hisayoshi
    Itani, Satoru
    Nakamura, Makoto
    Iwasaki, Yuichi
    Tsujimura, Yoshitaka
    ACTA MEDICA OKAYAMA, 2019, 73 (06) : 537 - 542
  • [49] Ovarian Reserve in Children with Juvenile Idiopathic Arthritis Using Biologic Disease-Modifying Anti-Rheumatic Drugs
    Ozer, Yavuz
    Yildiz, Mehmet
    Turan, Hande
    Tarcin, Gurkan
    Aydin, Dilek Bingol
    Gunalp, Aybuke
    Haslak, Fatih
    Konte, Elif Kilic
    Aslan, Esma
    Koker, Oya
    Bayramoglu, Elvan
    Sahin, Sezgin
    Adrovic, Amra
    Barut, Kenan
    Kasapcopur, Ozgur
    Evliyaoglu, Olcay
    HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 : 400 - 400
  • [50] Estimation of Cost per Effectively Treated Patients with Biologic Disease Modifying Anti-Rheumatic Drugs in US Veterans with Rheumatoid Arthritis
    Cannon, Grant W.
    Teng, Chia-Chen
    He, Tao
    Leng, Jianwei
    Lu, Chao-Chin
    Tang, Derek
    Shah, Neel
    Harrison, David J.
    Sauer, Brian
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S213 - S213
12345